450 related articles for article (PubMed ID: 9102217)
21. Evaluation of organoselenium compounds for potential chemopreventive properties in colon cancer.
Reddy BS; Wynn TT; el-Bayoumy K; Upadhyaya P; Fiala E; Rao CV
Anticancer Res; 1996; 16(3A):1123-7. PubMed ID: 8702223
[TBL] [Abstract][Full Text] [Related]
22. Age-related differential responses to curcumin-induced apoptosis during the initiation of colon cancer in rats.
Kwon Y; Magnuson BA
Food Chem Toxicol; 2009 Feb; 47(2):377-85. PubMed ID: 19095035
[TBL] [Abstract][Full Text] [Related]
23. Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice.
Huang MT; Lou YR; Ma W; Newmark HL; Reuhl KR; Conney AH
Cancer Res; 1994 Nov; 54(22):5841-7. PubMed ID: 7954412
[TBL] [Abstract][Full Text] [Related]
24. Effect of chemopreventive agents on intermediate biomarkers during different stages of azoxymethane-induced colon carcinogenesis.
Singh J; Kelloff G; Reddy BS
Cancer Epidemiol Biomarkers Prev; 1992; 1(5):405-11. PubMed ID: 1305473
[TBL] [Abstract][Full Text] [Related]
25. Chemoprevention of colon carcinogenesis by concurrent administration of piroxicam, a nonsteroidal antiinflammatory drug with D,L-alpha-difluoromethylornithine, an ornithine decarboxylase inhibitor, in diet.
Reddy BS; Nayini J; Tokumo K; Rigotty J; Zang E; Kelloff G
Cancer Res; 1990 May; 50(9):2562-8. PubMed ID: 2109653
[TBL] [Abstract][Full Text] [Related]
26. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis.
Kawamori T; Rao CV; Seibert K; Reddy BS
Cancer Res; 1998 Feb; 58(3):409-12. PubMed ID: 9458081
[TBL] [Abstract][Full Text] [Related]
27. Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.
Rao CV; Rivenson A; Simi B; Zang E; Kelloff G; Steele V; Reddy BS
Cancer Res; 1995 Apr; 55(7):1464-72. PubMed ID: 7882354
[TBL] [Abstract][Full Text] [Related]
28. Enhancement of experimental colon carcinogenesis by dietary 6-phenylhexyl isothiocyanate.
Rao CV; Rivenson A; Simi B; Zang E; Hamid R; Kelloff GJ; Steele V; Reddy BS
Cancer Res; 1995 Oct; 55(19):4311-8. PubMed ID: 7671241
[TBL] [Abstract][Full Text] [Related]
29. Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid.
Earnest DL; Holubec H; Wali RK; Jolley CS; Bissonette M; Bhattacharyya AK; Roy H; Khare S; Brasitus TA
Cancer Res; 1994 Oct; 54(19):5071-4. PubMed ID: 7923119
[TBL] [Abstract][Full Text] [Related]
30. Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination.
Rao CV; Tokumo K; Rigotty J; Zang E; Kelloff G; Reddy BS
Cancer Res; 1991 Sep; 51(17):4528-34. PubMed ID: 1831401
[TBL] [Abstract][Full Text] [Related]
31. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis.
Singh J; Hamid R; Reddy BS
Cancer Res; 1997 Aug; 57(16):3465-70. PubMed ID: 9270014
[TBL] [Abstract][Full Text] [Related]
32. Chemopreventive effect of S-methylmethane thiosulfonate and sulindac administered together during the promotion/progression stages of colon carcinogenesis.
Reddy BS; Kawamori T; Lubet R; Steele V; Kelloff G; Rao CV
Carcinogenesis; 1999 Aug; 20(8):1645-8. PubMed ID: 10426822
[TBL] [Abstract][Full Text] [Related]
33. Estrogen receptor-beta as a potential target for colon cancer prevention: chemoprevention of azoxymethane-induced colon carcinogenesis by raloxifene in F344 rats.
Janakiram NB; Steele VE; Rao CV
Cancer Prev Res (Phila); 2009 Jan; 2(1):52-9. PubMed ID: 19139018
[TBL] [Abstract][Full Text] [Related]
34. Effect of dietary excess of inorganic selenium during initiation and postinitiation phases of colon carcinogenesis in F344 rats.
Reddy BS; Sugie S; Maruyama H; Marra P
Cancer Res; 1988 Apr; 48(7):1777-80. PubMed ID: 3349457
[TBL] [Abstract][Full Text] [Related]
35. Ursodeoxycholic acid inhibits the initiation and postinitiation phases of azoxymethane-induced colonic tumor development.
Wali RK; Stoiber D; Nguyen L; Hart J; Sitrin MD; Brasitus T; Bissonnette M
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1316-21. PubMed ID: 12433708
[TBL] [Abstract][Full Text] [Related]
36. Chemoprevention of azoxymethane-induced colon cancer by ascorbylpalmitate, carbenoxolone, dimethylfumarate and p-methoxyphenol in male F344 rats.
Rao CV; Rivenson A; Kelloff GJ; Reddy BS
Anticancer Res; 1995; 15(4):1199-204. PubMed ID: 7653999
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of organoselenium compounds for potential chemopreventive properties in colon carcinogenesis.
Reddy BS; Upadhyaya P; Simi B; Rao CV
Anticancer Res; 1994; 14(6B):2509-14. PubMed ID: 7872674
[TBL] [Abstract][Full Text] [Related]
38. A water-soluble extract from cultured medium of Ganoderma lucidum (Rei-shi) mycelia suppresses azoxymethane-induction of colon cancers in male F344 rats.
Lu H; Kyo E; Uesaka T; Katoh O; Watanabe H
Oncol Rep; 2003; 10(2):375-9. PubMed ID: 12579275
[TBL] [Abstract][Full Text] [Related]
39. Anti-carcinogenic properties of omeprazole against human colon cancer cells and azoxymethane-induced colonic aberrant crypt foci formation in rats.
Patlolla JM; Zhang Y; Li Q; Steele VE; Rao CV
Int J Oncol; 2012 Jan; 40(1):170-5. PubMed ID: 21956158
[TBL] [Abstract][Full Text] [Related]
40. The NSAID sulindac is chemopreventive in the mouse distal colon but carcinogenic in the proximal colon.
Mladenova D; Daniel JJ; Dahlstrom JE; Bean E; Gupta R; Pickford R; Currey N; Musgrove EA; Kohonen-Corish MR
Gut; 2011 Mar; 60(3):350-60. PubMed ID: 20980345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
